Literature Citations
1. New Indole and Indazole Derivatives as Potential Antimycobacterial Agents. Angelova, V.T., T. Pencheva, N. Vassilev, R. Simeonova, G. Momekov, and V. Valcheva. Medicinal Chemistry Research, 2019. 28(4): p. 485-497. ISI[000462753900006].
[WOS]. TB_04_2019.
2. Design, Synthesis and Biological Evaluation of (E)-5-Styryl-1,2,4-oxadiazoles as Anti-tubercular Agents. Atmaram Upare, A., P.K. Gadekar, H. Sivaramakrishnan, N. Naik, V.M. Khedkar, D. Sarkar, A. Choudhari, and S. Mohana Roopan. Bioorganic Chemistry, 2019. 86: p. 507-512. PMID[30776681].
[PubMed]. TB_04_2019.
3. Design and Synthesis of 2-Amino-thiophene-proline-conjugates and Their Anti-tubercular Activity against Mycobacterium tuberculosis H37Ra. Baravkar, S.B., M.A. Wagh, L.U. Nawale, A.S. Choudhari, S. Bhansali, D. Sarkar, and G.J. Sanjayan. ChemistrySelect, 2019. 4(9): p. 2851-2857. ISI[000462083500047].
[WOS]. TB_04_2019.
4. Structure-Activity Relationships for Unit C Pyridyl Analogues of the Tuberculosis Drug Bedaquiline. Blaser, A., H.S. Sutherland, A.S.T. Tong, P.J. Choi, D. Conole, S.G. Franzblau, C.B. Cooper, A.M. Upton, M. Lotlikar, W.A. Denny, and B.D. Palmer. Bioorganic & Medicinal Chemistry, 2019. 27(7): p. 1283-1291. PMID[30792104]. PMCID[PMC6467542].
[PubMed]. TB_04_2019.
5. Click-tailed Benzenesulfonamides as Potent Bacterial Carbonic Anhydrase Inhibitors for Targeting Mycobacterium tuberculosis and Vibrio cholerae. Bua, S., S.M. Osman, S. Del Prete, C. Capasso, Z. AlOthman, A. Nocentini, and C.T. Supuran. Bioorganic Chemistry, 2019. 86: p. 183-186. PMID[30716618].
[PubMed]. TB_04_2019.
6. New Insight into Structure-activity of Furan-based Salicylate Synthase (MbtI) Inhibitors as Potential Antitubercular Agents. Chiarelli, L.R., M. Mori, G. Beretta, A. Gelain, E. Pini, J.C. Sammartino, G. Stelitano, D. Barlocco, L. Costantino, M. Lapillo, G. Poli, I. Caligiuri, F. Rizzolio, M. Bellinzoni, T. Tuccinardi, S. Villa, and F. Meneghetti. Journal of Enzyme Inhibition and Medicinal Chemistry, 2019. 34(1): p. 823-828. PMID[30889995]. PMCID[PMC6427685].
[PubMed]. TB_04_2019.
7. Double Prodrugs of a Fosmidomycin Surrogate as Antimalarial and Antitubercular Agents. Courtens, C., M. Risseeuw, G. Caljon, L. Maes, P. Cos, A. Martin, and S. Van Calenbergh. Bioorganic & Medicinal Chemistry Letters, 2019. 29(10): p. 1232-1235. PMID[30879839].
[PubMed]. TB_04_2019.
8. Spectral, Electrochemical and DFT Studies of a Trimetallic Cu-II Derivative: Antimycobacterial and Cytotoxic Activity. Das, K., S. Goswami, B.B. Beyene, A.W. Yibeltal, C. Massera, E. Garribba, A. Frontera, Z. Canturk, T. Askun, and A. Datta. Inorganica Chimica Acta, 2019. 490: p. 155-162. ISI[000463348300019].
[WOS]. TB_04_2019.
9. Synthesis and Biological Evaluation of Novel cYY Analogues Targeting Mycobacterium tuberculosis CYP121A1. Kishk, S.M., K.J. McLean, S. Sood, M.A. Helal, M.S. Gomaa, I. Salama, S.M. Mostafa, L.P.S. de Carvalho, A.W. Munro, and C. Simons. Bioorganic & Medicinal Chemistry, 2019. 27(8): p. 1546-1561. PMID[30837169].
[PubMed]. TB_04_2019.
10. In Vitro and Intracellular Activity of Imipenem Combined with Tedizolid, Rifabutin, and Avibactam against Mycobacterium abscessus. Le Run, E., M. Arthur, and J.L. Mainardi. Antimicrobial Agents and Chemotherapy, 2019. 63(4): e01915-01918. PMID[30745387]. PMCID[PMC6437523].
[PubMed]. TB_04_2019.
11. Discovery of Meta-amido Bromophenols as New Antitubercular Agents. Liang, J., Y.X. Tang, X.Z. Tang, H.J. Liang, Y. Gao, C. Fang, T.Y. Zhang, and M. Yan. Chemical and Pharmaceutical Bulletin, 2019. 67(4): p. 372-381. PMID[30686792].
[PubMed]. TB_04_2019.
12. Design, Synthesis and Molecular Docking Studies of Quinazolin-4-ones Linked to 1,2,3-Triazol Hybrids as Mycobacterium tuberculosis H(37)Rv Inhibitors Besides Antimicrobial Activity. Maddali, N.K., I.V.K. Viswanath, Y.L.N. Murthy, R. Bera, M. Takhi, N.S. Rao, and V. Gudla. Medicinal Chemistry Research, 2019. 28(4): p. 559-570. ISI[000462753900012].
[WOS]. TB_04_2019.
13. Discovery of Lipophilic Bisphosphonates That Target Bacterial Cell Wall and Quinone Biosynthesis. Malwal, S.R., L. Chen, H. Hicks, F. Qu, W. Liu, A. Shillo, W.X. Law, J. Zhang, N. Chandnani, X. Han, Y. Zheng, C.C. Chen, R.T. Guo, A. AbdelKhalek, M.N. Seleem, and E. Oldfield. Journal of Medicinal Chemistry, 2019. 62(5): p. 2564-2581. PMID[30730737]. PMCID[PMC6427912].
[PubMed]. TB_04_2019.
14. Identification of Some Novel Pyrazolo[1,5-a]pyrimidine Derivatives as InhA Inhibitors through Pharmacophore-based Virtual Screening and Molecular Docking. Modi, P., S. Patel, and M.T. Chhabria. Journal of Biomolecular Structure and Dynamics, 2019. 37(7): p. 1736-1749. PMID[29663870].
[PubMed]. TB_04_2019.
15. Impact of Tetracationic Calix[4]arene Conformation-from Conic Structure to Expanded Bolaform-on Their Antibacterial and Antimycobacterial Activities. Mourer, M., R.E. Duval, P. Constant, M. Daffe, and J.B. Regnouf-de-Vains. ChemBioChem, 2019. 20(7): p. 911-921. PMID[30512240].
[PubMed]. TB_04_2019.
16. Synthesis, Characterization and Antibacterial Activity of Cu (II) and Zn (II) Complexes of 5-Aminobenzofuran-2-carboxylate Schiff Base Ligands. Nazirkar, B., M. Mandewale, and R. Yamgar. Journal of Taibah University for Science, 2019. 13(1): p. 440-449. ISI[000461634300001].
[WOS]. TB_04_2019.
17. Using 2-Aminobenzimidazole Derivatives to Inhibit Mycobacterium smegmatis Biofilm Formation. Nguyen, T.V., M.T. Peszko, R.J. Melander, and C. Melander. MedChemComm, 2019. 10(3): p. 456-459. PMID[31015909]. PMCID[PMC6457209].
[PubMed]. TB_04_2019.
18. Synthesis and Antitubercular Evaluation of Fluorinated 2-Cycloalkylimino Substituted 1,3-Benzothiazin-4-ones. Nosova, E.V., O.A. Batanova, G.N. Lipunova, and S.K. Kotovskaya. Journal of Fluorine Chemistry, 2019. 220: p. 69-77. ISI[000463978800010].
[WOS]. TB_04_2019.
19. Pyridine and Nitro-phenyl Linked 1,3,4-Thiadiazoles as MDR-TB Inhibitors. Patel, H., H. Jadhav, I. Ansari, R. Pawara, and S. Surana. European Journal of Medicinal Chemistry, 2019. 167: p. 1-9. PMID[30743094].
[PubMed]. TB_04_2019.
20. Repurposing Artemisinin as an Anti-mycobacterial Agent in Synergy with Rifampicin. Patel, Y.S., N. Mistry, and S. Mehra. Tuberculosis, 2019. 115: p. 146-153. PMID[30948170].
[PubMed]. TB_04_2019.
21. A Fragment-based Approach Towards the Discovery of N-substituted Tropinones as Inhibitors of Mycobacterium tuberculosis Transcriptional Regulator EthR2. Prevet, H., M. Moune, A. Tanina, C. Kemmer, A. Herledan, R. Frita, A. Wohlkonig, M. Bourotte, B. Villemagne, F. Leroux, M. Gitzinger, A.R. Baulard, B. Deprez, R. Wintjens, N. Willand, and M. Flipo. European Journal of Medicinal Chemistry, 2019. 167: p. 426-438. PMID[30784877].
[PubMed]. TB_04_2019.
22. Synthesis, Docking and Antibacterial Studies of More Potent Amine and Hydrazone Rifamycin Congeners Than Rifampicin. Pyta, K., A. Janas, M. Szukowska, P. Pecyna, M. Jaworska, M. Gajecka, F. Bartl, and P. Przybylski. European Journal of Medicinal Chemistry, 2019. 167: p. 96-104. PMID[30769243].
[PubMed]. TB_04_2019.
23. Synthesis, Anti-mycobacterial and Cytotoxic Evaluation of Substituted Isoindoline-1,3-dione-4-aminoquinolines Coupled via Alkyl/Amide Linkers. Rani, A., A. Viljoen, M.D. Johansen, L. Kremer, and V. Kumar. RSC Advances, 2019. 9(15): p. 8515-8528. ISI[000461445300045].
[WOS]. TB_04_2019.
24. Quinoline-1,2,3-triazole Hybrids: Design and Synthesis through Click Reaction, Evaluation of Anti-tubercular Activity, Molecular Docking and in Silico ADME Studies. Reddyrajula, R., and U. Dalimba. ChemistrySelect, 2019. 4(9): p. 2685-2693. ISI[000462083500024].
[WOS]. TB_04_2019.
25. Molecular Hybridization Approach for Phenothiazine Incorporated 1,2,3-Triazole Hybrids as Promising Antimicrobial Agents: Design, Synthesis, Molecular Docking and in Silico ADME Studies. Reddyrajula, R., U. Dalimba, and S. Madan Kumar. European Journal of Medicinal Chemistry, 2019. 168: p. 263-282. PMID[30822714].
[PubMed]. TB_04_2019.
26. A Bedaquiline/Clofazimine Combination Regimen Might Add Activity to the Treatment of Clinically Relevant Non-tuberculous Mycobacteria. Ruth, M.M., J.J.N. Sangen, K. Remmers, L.J. Pennings, E. Svensson, R.E. Aarnoutse, S.M.H. Zweijpfenning, W. Hoefsloot, S. Kuipers, C. Magis-Escurra, H.F.L. Wertheim, and J. van Ingen. Journal of Antimicrobial Chemotherapy, 2019. 74(4): p. 935-943. PMID[30649327].
[PubMed]. TB_04_2019.
27. Synthesis and Investigation of Phthalazinones as Antitubercular Agents. Santoso, K.T., C.Y. Cheung, K. Hards, G.M. Cook, B.L. Stocker, and M.S.M. Timmer. Chemistry - An Asian Journal, 2019. 14(8): p. 1278-1285. PMID[30680937].
[PubMed]. TB_04_2019.
28. In Vitro Activities of Omadacycline against Rapidly Growing Mycobacteria. Shoen, C., D. Benaroch, M. Sklaney, and M. Cynamon. Antimicrobial Agents and Chemotherapy, 2019. 63(5): p. e02522-02518. PMID[30858221].
[PubMed]. TB_04_2019.
29. Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus in Vitro. Story-Roller, E., E.C. Maggioncalda, and G. Lamichhane. Antimicrobial Agents and Chemotherapy, 2019. 63(4): e02613-02618. PMID[30745389]. PMCID[PMC6437493].
[PubMed]. TB_04_2019.
30. Thiazolyl-pyrazole Derivatives as Potential Antimycobacterial Agents. Takate, S.J., A.D. Shinde, B.K. Karale, H. Akolkar, L. Nawale, D. Sarkar, and P.C. Mhaske. Bioorganic & Medicinal Chemistry Letters, 2019. 29(10): p. 1199-1202. PMID[30910461].
[PubMed]. TB_04_2019.
31. Benzaldehyde thiosemicarbazone Derivatives against Replicating and Nonreplicating Mycobacterium tuberculosis. Volynets, G.P., M.A. Tukalo, V.G. Bdzhola, N.M. Derkach, M.I. Gumeniuk, S.S. Tarnavskiy, S.A. Starosyla, and S.M. Yarmoluk. Journal of Antibiotics, 2019. 72(4): p. 218-224. PMID[30662064].
[PubMed]. TB_04_2019.
32. Discovery and Development of Novel Rhodanine Derivatives Targeting Enoyl-Acyl Carrier Protein reductase. Xu, J.F., T.T. Wang, Q. Yuan, Y.T. Duan, Y.J. Xu, P.C. Lv, X.M. Wang, Y.S. Yang, and H.L. Zhu. Bioorganic & Medicinal Chemistry, 2019. 27(8): p. 1509-1516. PMID[30846404].
[PubMed]. TB_04_2019.
33. Design, Synthesis, and Antitubercular Activity of 3-Amidophenols with 5-Heteroatomic Substitutions. Zhang, N.N., Y.X. Tang, L. Qian, Y.M. Gao, Z.Y. Liu, Z.L. Zou, T.Y. Zhang, and M. Yan. Archiv der Pharmazie, 2019. 352(4): e1800277. PMID[30698293].
[PubMed]. TB_04_2019.
34. Identification of Novel Coumestan Derivatives as Polyketide synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II. Zhang, W., S. Lun, L.L. Liu, S. Xiao, G. Duan, H. Gunosewoyo, F. Yang, J. Tang, W.R. Bishai, and L.F. Yu. Journal of Medicinal Chemistry, 2019. 62(7): p. 3575-3589. PMID[30875203].
[PubMed]. TB_04_2019.
Patent Citations
35. Carboxamide Derivatives as Peptidomimetic Proteasome Inhibitors and Their Preparation. Lin, G., C. Nathan, W. Zhan, T. Morgan, R. Hara, T. Imaeda, R. Okamoto, K. Sato, K. Aso, T.-T. Wong, and M.A. Foley. Patent. 2019. 2018-US55482 2019075252: 245pp.
[Patent]. TB_04_2019.
36. Preparation of Ring-fused Thiazolino 2-pyridones and Their Use in a Combination with a Drug against Tuberculosis. Stallings, C.L., G.A. Harrison, F. Almqvist, and S. Sarkar. Patent. 2019. 2018-EP77222 2019068910: 105pp.
[Patent]. TB_04_2019.